Ensysce Biosciences, Inc. (ENSC)
NASDAQ: ENSC · Real-Time Price · USD
0.602
-0.054 (-8.16%)
Nov 21, 2024, 12:24 PM EST - Market open
Ensysce Biosciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 12 | 3 | 5 | 114 | 18,673 | 15,354 |
| Market Cap Growth | -33.43% | -30.67% | -95.78% | -99.39% | 21.62% | - |
| Enterprise Value | 9 | 2 | 9 | 112 | 18,676 | - |
| Last Close Price | 0.66 | 1.06 | 9.00 | 1128.00 | 2984.33 | 2500.80 |
| PE Ratio | - | - | - | - | 3552.78 | - |
| PS Ratio | 0.96 | 1.50 | 1.91 | 32.28 | 4750.02 | 8704.12 |
| PB Ratio | 1.32 | -5.12 | -1.19 | -13.97 | -2804.47 | -2299.75 |
| EV/Sales Ratio | 1.98 | 0.85 | 3.55 | 31.67 | 4750.60 | - |
| Debt / Equity Ratio | 0.06 | -1.31 | -1.10 | -2.11 | -0.64 | -0.39 |
| Asset Turnover | 0.70 | 0.52 | 0.23 | 0.42 | 8.06 | - |
| Quick Ratio | 2.12 | 0.37 | 0.36 | 0.77 | 0.03 | 0.07 |
| Current Ratio | 3.24 | 0.69 | 0.56 | 0.95 | 0.05 | 0.08 |
| Return on Assets (ROA) | -62.58% | -155.91% | -135.76% | -148.12% | -206.67% | - |
| Return on Capital (ROIC) | -93.02% | -2204.12% | -320.05% | -372.49% | - | - |
| Earnings Yield | -65.32% | -318.25% | -502.54% | -25.51% | 0.00% | -0.07% |
| FCF Yield | -70.37% | -323.25% | -371.88% | -7.23% | -0.01% | -0.01% |
| Buyback Yield / Dilution | -285.29% | -1158.34% | -114.15% | -22.15% | 93.11% | - |
| Total Shareholder Return | -285.29% | -1158.34% | -114.15% | -22.15% | 93.11% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.